Haleon HLN
NYSE HLN
$9.88 +0.01 (+0.05%)
At close: Aug 20, 2026 · 2:04 PM UTC

Haleon (HLN) Total Debt Growth (1y) (2022 - 2025)

Haleon (HLN) Total Debt Growth (1y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -3.69%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 37.49%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -2.48%
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 4.38%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -6.91%
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - 41.53%
10 Alkermes 8.11 Bn 7.46 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -171.51%
Dec 31, 2024 10.75%
Jun 30, 2024 21.68%
Dec 31, 2023 -4.16%
Jun 30, 2023 23.14%
Dec 31, 2022 5,372.31%